TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Genentech names new CEO Ian Clark, who formerly headed up Genentech’s commercial operations, will become the South San Francisco biotech’s new CEO as of Jan. 1. feeds.bizjournals.com |
BioClinica Showcases Clinical Data Management at SCDM Annual Conference (Business Wire) NEWTOWN, Pa.----BioClinica, Inc., a leading global provider of clinical trial services, is helping to advance the discipline of clinical data management and will demonstrate integrated eClinical and imaging data management technology and expertise at the 2009 Society of Clinical Data Management Annual Conference, October 4-6, 2009 in Seattle, WA . us.rd.yahoo.com |
Aetna Earnings Rise 18% Aetna's profit rose 18% amid better returns from its investments, while costs related to the H1N1 flu hurt margins at its commercial plans. online.barrons.com |
Genzyme's Renagel / Renvela Franchise: Investors Would Be Wise to Reevaluate This is a follow up to my previous post regarding the news that development of Genzyme’s (GENZ) follow-on product to its Renagel/Renvela franchise is being discontinued. The product, named GENZ-644470, is an advanced phosphate binder (APB) that was hoped to have demonstrated a superior clinical profile compared to predecessor Renvela. The drug worked at reducing serum phosphorus levels in patients with chronic kidney disease; however, it did not outperform Renvela in this regard.In my opinion, this is a significant setback for Genzyme. Sales of its Renagel/Renvela franchise were approximately $680 million in 2008, making it Genzyme's second-best selling product behind flagship Gaucher disease drug Cerezyme. The product also has significant opportunity for label expansion, particularly in CKD patients not on dialysis. As a result, this is a product with significant growth potential for Genzyme in coming years.Complete Story » seekingalpha.com |
Cord Blood America Grand Opening Available for Investor Viewing (PR Newswire) Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that the Grand Opening of its Las Vegas corporate office and laboratory, which occurred on Friday, January 22, 2010, is now available for viewing at its website. Â The internet address is: Â http://www.cordblood-america.com/grandopening us.rd.yahoo.com |